Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a walking group keep seniors on their feet? new trial tests fall prevention

NCT ID NCT07368907

Prevention Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests whether a 12-week group walking program, called Walk On!, can help prevent falls in older adults who have trouble moving or feel socially isolated. Researchers will enroll 192 participants aged 60 and older at community sites. The program includes twice-weekly walking sessions focused on endurance, strength, and balance. The study will measure how well community organizations can run the program and whether it reduces falls and fear of falling.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Walk On! Program (group walking sessions)
What this could lead to
If it works, this could provide a simple, community-based program to reduce falls and improve confidence in older adults.
What could go wrong
This is an early, single-arm trial without a comparison group, so results may not prove the program directly prevents falls. Success depends on community organizations adopting and sustaining the program.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 192 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Program Older Adult Participants: Inclusion Criteria: * Age greater than or equal to 60 years * Able to provide own transportation to the program each week * No planned extended travel or time away during the 12 week program period * English speaking with intact verbal and written communication skills * Free of current fracture * Able to ambulate independently, with or without an assistive device (i.e., cane or walker) Program Participants: Exclusion Criteria: * Serious or unstable medical or psychiatric condition that would prevent participation in research study * Lack of decision-making capacity * Participated in an evidence-based falls prevention program within the past 12 months Community-Based Organizations (CBOs): Inclusion Criteria: * Age greater than or equal to 18 years * English speaking Community-Based Organizations (CBOs): Exclusion Criteria: * Not interested in offering a Walk On! program * Unwilling and/or unable to participate in implementation activities

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Falls prevention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Mobility Limitation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Falls prevention

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Wake Forest University School of Medicine

    RECRUITING

    Winston-Salem, North Carolina, 27101, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.